Total-Body Parametric 18F-FDG PET of COVID-19

University of California (UC) Davis

Status: Completed

Conditions: Covid19

Treatments: Device: uEXPLORER/mCT

Study type: Interventional

Funder types: Other

Identifiers

NCT04841707

1697954

Details and patient eligibility

About

The primary objective is to measure the change between COVID-19 patients and normal subjects; the secondary objective is to measure the change in COVID-19 patients between baseline and 4-month follow up.

Enrollment: 13 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• COVID-19 positive patients will have a previous positive COVID-19 test and radiographic findings, and/or a positive SARS-CoV-2 antibody test and be in early recovery.
• First PET/CT visit needs to be within 8 weeks of COVID-19 diagnosis.
• Ability to understand and willingness to sign an informed consent form.
• Ability to adhere to the study visit schedule and other protocol requirements.
• All persons ≥18 years of age.

Exclusion criteria

• Pregnant or lactating women.
• Any condition that would prohibit the understanding or rendering of informed consent.
• Unable to lie supine for 1-hour imaging with PET.
• Prisoners.
• Any comorbidity that, in the opinion of the investigator, could compromise protocol objectives.

Trial design

Primary purpose: Basic Science

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

13 participants in 1 patient group

COVID-19 patients

Experimental group

Treatment:

Device: uEXPLORER/mCT